Deaths After Readmissions are Mostly Attributable to Failure-to-Rescue in EGS Patients
The American Surgeon™ · 2024
DOI: 10.1177/00031348241248796 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Surgeon™, 2024. Verfasst von Raul Coimbra und 9 weiteren Autor:innen. Beteiligte Einrichtung: Comparative Effectiveness and Clinical Outcomes Research Center, Riverside University Health System, Moreno Valley, CA, USA. Hauptthemen laut MEDLINE: Patient Readmission, Postoperative Complications, Failure to Rescue, Health Care. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Introduction
We have recently shown that readmission after EGS procedures carries a 4-fold higher mortality rate when compared to those not readmitted. Understanding factors associated with death after readmission is paramount to improving outcomes for EGS patients. We aimed to identify risk factors contributing to failure-to-rescue (FTR) during readmission after EGS. We hypothesized that most post-readmission deaths in EGS are attributable to FTR.
Methods
A retrospective cohort study using the NSQIP database 2013-2019 was performed. Patients who underwent 1 of 9 urgent/emergent surgical procedures representing 80% of EGS burden of disease, who were readmitted within 30 days post-procedure were identified. The procedures were classified as low- and high-risk. Patient characteristics analyzed included age, sex, BMI, ASA score comorbidities, postoperative complications, frailty, and FTR. The population was assessed for risk factors associated with mortality and FTR by uni- and multivariate logistic regression.
Results
Of 312,862 EGS cases, 16,306 required readmission. Of those, 10,748 (3.4%) developed a postoperative complication. Overall mortality after readmission was 2.4%, with 90.6% of deaths attributable to FTR. Frailty, high-risk procedures, pulmonary complications, AKI, sepsis, and the need for reoperation increased the risk of FTR.
Discussion
Death after a complication is common in EGS readmissions. The impact of FTR could be minimized with the implementation of measures to allow early identification and intervention or prevention of infectious, respiratory, and renal complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Comparative Effectiveness and Clinical Outcomes Research Center, Riverside University Health System, Moreno Valley, CA, USA.
- Division of Trauma and Acute Care Surgery, Riverside University Health System Medical Center, Department of Surgery, University of California Riverside, Moreno Valley, CA, USA.
- Department of Trauma Surgery, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Trauma Surgery, Ajou University School of Medicine, Seoul, Republic of Korea.
- George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
- Division of Trauma, Surgical Critical Care and Burns, Department of Surgery, University of California San Diego, San Diego, CA, USA.
ORCID-Profile: Bishoy Zakhary, Junsik Kwon
Zitieren
APA
Coimbra, R., Kim, M., Allison-Aipa, T., Zakhary, B., Kwon, J., Firek, M., Coimbra, B. C., Costantini, T. W., Haynes, L. N., & Edwards, S. B. (2024). Deaths After Readmissions are Mostly Attributable to Failure-to-Rescue in EGS Patients. The American Surgeon™. https://doi.org/10.1177/00031348241248796
Vancouver
Coimbra R, Kim M, Allison-Aipa T, Zakhary B, Kwon J, Firek M, et al. Deaths After Readmissions are Mostly Attributable to Failure-to-Rescue in EGS Patients. The American Surgeon™. 2024. doi:10.1177/00031348241248796
BibTeX
@article{Coimbra2024,
author = {Coimbra, Raul and Kim, Maru and Allison-Aipa, Timothy and Zakhary, Bishoy and Kwon, Junsik and Firek, Matthew and Coimbra, Bruno Cammarota and Costantini, Todd W and Haynes, Laura N and Edwards, Sara B},
title = {Deaths After Readmissions are Mostly Attributable to Failure-to-Rescue in EGS Patients},
journal = {The American Surgeon™},
year = {2024},
doi = {10.1177/00031348241248796}
}
EUVIMED